Sun Pharmaceutical Industries Inc. is recalling 9,840 bottles of Morphine Sulfate Extended-Release Tablets (100 mg). This recall was initiated because the tablets failed dissolution specifications, meaning the drug may not release into the body as intended. The affected 100-count bottles were distributed nationwide in the United States.
If the medication fails to dissolve correctly, it may result in the patient not receiving the required dose for pain management or, conversely, could lead to too much medication being released at once, increasing the risk of respiratory depression or overdose.
You have 2 options:
Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.